Silvio Roggo

3.1k total citations
28 papers, 1.8k citations indexed

About

Silvio Roggo is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Silvio Roggo has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Computational Theory and Mathematics and 5 papers in Pharmacology. Recurrent topics in Silvio Roggo's work include Computational Drug Discovery Methods (7 papers), Chemical Synthesis and Analysis (4 papers) and Molecular spectroscopy and chirality (4 papers). Silvio Roggo is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Chemical Synthesis and Analysis (4 papers) and Molecular spectroscopy and chirality (4 papers). Silvio Roggo collaborates with scholars based in Switzerland, United States and Germany. Silvio Roggo's co-authors include Peter Ertl, Ansgar Schuffenhauer, Dieter Seebàch, Albert K. Beck, Anne Wonnacott, Herbert Waldmann, Stefan Wetzel, Мarcus A. Koch, P. C. Waldmeier and Kaspar Zimmermann and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Silvio Roggo

28 papers receiving 1.8k citations

Peers

Countries citing papers authored by Silvio Roggo

Since Specialization

Citations

This map shows the geographic impact of Silvio Roggo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio Roggo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio Roggo more than expected).

Fields of papers citing papers by Silvio Roggo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio Roggo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio Roggo. The network helps show where Silvio Roggo may publish in the future.

Co-authorship network of co-authors of Silvio Roggo

This figure shows the co-authorship network connecting the top 25 collaborators of Silvio Roggo. A scholar is included among the top collaborators of Silvio Roggo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvio Roggo. Silvio Roggo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design of greener drugs: aligning parameters in pharmaceutical R&D and drivers for environmental impact 2024 ·Drug Discovery Today ·(unknown), (unknown), (unknown), Stewart F. Owen, Daniela Angst, Caroline Moermond, Bastiaan J. Venhuis, Anna Lombardo, Klaus Kümmerer, Tiina Sikanen, (unknown), Andreas Häner, Gemma Janer, Silvio Roggo, (unknown)	8
2	Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol 2020 ·Nature Communications ·Yue Fu, David Estoppey, Silvio Roggo, Dominik Pistorius, Florian Fuchs, Christian Studer, Ashraf S. Ibrahim, Thomas Aust, (unknown), (unknown), Klaus Memmert, (unknown), (unknown), Ralph Riedl, Sven Schuierer, Eric Weber, Jürg Hunziker, Frank Petersen, Jianshi Tao, Dominic Hoepfner	32
3	Auxin-Inducible Depletion of the Essentialome Suggests Inhibition of TORC1 by Auxins and Inhibition of Vrg4 by SDZ 90-215, a Natural Antifungal Cyclopeptide 2019 ·G3 Genes Genomes Genetics ·Nathan Snyder, Adam Kim, (unknown), Andrew N. Gale, Christian Studer, Dominic Hoepfner, Silvio Roggo, Stephen B. Helliwell, Kyle W. Cunningham	17
4	Total synthesis of diaportheone A 2018 ·Tetrahedron Letters ·Mario A. Tan, (unknown), Silvio Roggo	3
5	Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action 2015 ·ChemBioChem ·(unknown), Silvio Roggo, Nils Ostermann, Jutta Blank, (unknown), Felix Freuler, Bernd Gerhartz, Alexandra Hinniger, Dominic Hoepfner, (unknown), (unknown), (unknown), Dominik Pistorius, Matthias Rottmann, Jason R. Thomas, Markus Schirle, E. Schmitt	39
6	Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex 2013 ·ACS Chemical Biology ·Heather Sadlish, Gabriela Galicia-Vázquez, C. Paris, Thomas Aust, Bhupinder Bhullar, Lena Chang, Stephen B. Helliwell, Dominic Hoepfner, Britta Knapp, Ralph Riedl, Silvio Roggo, Sven Schuierer, Christian Studer, John A. Porco, Jerry Pelletier, N. Rao Movva	88
7	The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease 2011 ·Angewandte Chemie International Edition ·E. Schmitt, (unknown), Vasan K. Sambandamurthy, Silvio Roggo, (unknown), Christian Zwingelstein, Philipp Krastel, Christian G. Noble, David Beer, Srinivasa P. S. Rao, Melvin Au, Pornwaratt Niyomrattanakit, (unknown), Jun Zheng, Douglas A. Jeffery, Kévin Pethe, Luis R. Camacho	141
8	Natural product-likeness score and its applications in the drug discovery process 2008 ·Chemistry Central Journal ·Peter Ertl, Silvio Roggo, Ansgar Schuffenhauer	3
9	Natural Products in Drug Discovery 2007 ·CHIMIA International Journal for Chemistry ·Silvio Roggo	37
10	Marine Natural Products. Key Advances to the Practical Application of this Resource in Drug Development 2007 ·CHIMIA International Journal for Chemistry ·Mark T. Hamann, Russell T. Hill, Silvio Roggo	16
11	Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries 2007 ·Journal of Chemical Information and Modeling ·Peter Ertl, Silvio Roggo, Ansgar Schuffenhauer	277
12	The Scaffold Tree − Visualization of the Scaffold Universe by Hierarchical Scaffold Classification 2006 ·Journal of Chemical Information and Modeling ·Ansgar Schuffenhauer, Peter Ertl, Silvio Roggo, Stefan Wetzel, Мarcus A. Koch, Herbert Waldmann	278
13	Structure–activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads 2005 ·Bioorganic & Medicinal Chemistry Letters ·Brett R. Ullman, Teresa Aja, Ning Chen, José-Luis Díaz, Xin Gu, Julia Herrmann, Vincent J. Kalish, Donald S. Karanewsky, Lalitha Kodandapani, (unknown), (unknown), (unknown), Kip Nalley, Edward D. Robinson, Silvio Roggo, Robert O. Sayers, Albert Schmitz, Robert J. Ternansky, Kevin J. Tomaselli, Joseph C. Wu	12
14	Structure–Activity relationships within a series of caspase inhibitors: effect of leaving group modifications 2003 ·Bioorganic & Medicinal Chemistry Letters ·Brett R. Ullman, Teresa Aja, Thomas L. Deckwerth, José-Luis Díaz, Julia Herrmann, Vincent J. Kalish, Donald S. Karanewsky, (unknown), Kip Nalley, Edward D. Robinson, Silvio Roggo, Robert O. Sayers, Albert Schmitz, Robert J. Ternansky, Kevin J. Tomaselli, Joseph C. Wu	14
15	Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Donald S. Karanewsky, Robert J. Ternansky, Ning Chen, (unknown), (unknown), Vincent J. Kalish, (unknown), Edward D. Robinson, Brett R. Ullman, Joseph C. Wu, (unknown), Lalitha Kodandapani, (unknown), José-Luis Díaz, Lawrence C. Fritz, (unknown), Silvio Roggo, Albert Schmitz, Kevin J. Tomaselli	9
16	Inhibition of BACE, a Promising Approach to Alzheimers Disease Therapy 2002 ·Current Topics in Medicinal Chemistry ·Silvio Roggo	49
17	Synthesis of tools for target identification of the anti-apoptotic compound CGP 3466; Part I 1998 ·Bioorganic & Medicinal Chemistry Letters ·Kaspar Zimmermann, Silvio Roggo, (unknown), Peter Fürst, P. C. Waldmeier	17
18	Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 and R-(−)-Deprenyl 1998 ·Journal of Biological Chemistry ·(unknown), (unknown), Kaspar Zimmermann, Silvio Roggo, Patrick Schindler, Dieter Müller, Jan van Oostrum, P. C. Waldmeier, Peter Fürst	177
19	A new class of inhibitors of secretory phospholipase A2: enolized 1,3-dioxane-4,6-dione-5-carboxamides 1994 ·European Journal of Medicinal Chemistry ·Werner Breitenstein, F. Märki, Silvio Roggo, Irmgard Wiesenberg, Josef Pfeilschifter, Pascal Furet, (unknown)	12
20	ChemInform Abstract: ENANTIOSELECTIVE ADDITION OF ARYL GROUPS TO AROMATIC ALDEHYDES USING CHIRAL ARYLTITANIUM BINAPHTHOL DERIVATIVES 1985 ·Chemischer Informationsdienst ·Dieter Seebàch, (unknown), Silvio Roggo, Anne Wonnacott	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact